<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>22(6)</volume><submitter>Yedavalli V</submitter><pubmed_abstract>Medium vessel occlusion (MeVO) contributes significantly to acute ischemic stroke (AIS). The hypoperfusion intensity ratio (HIR), reflecting collateral circulation via the ratio of Tmax >10s to Tmax >6s volumes, predicts infarct progression in large-vessel occlusions but is unstudied in MeVOs. In this multicenter, multinational retrospective study, we evaluated consecutive patients with MeVO who underwent mechanical thrombectomy with or without intravenous thrombolysis. Inclusion required available follow-up imaging and pretreatment CT perfusion. Follow-up infarct volume (FIV) was measured on CT or MRI 12-36 ​h post-procedure. Univariable and multivariable linear regression models were used to identify predictors of FIV, with HIR as the primary variable of interest. Among 147 patients (med</pubmed_abstract><journal>Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics</journal><pagination>e00713</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12664488</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Hypoperfusion intensity ratio is associated with follow-up infarct volume in medium vessel occlusions: A multicenter multinational study.</pubmed_title><pmcid>PMC12664488</pmcid><pubmed_authors>Pedicelli A</pubmed_authors><pubmed_authors>Filipe JP</pubmed_authors><pubmed_authors>Mohlenbruch MA</pubmed_authors><pubmed_authors>Barreau X</pubmed_authors><pubmed_authors>Yedavalli V</pubmed_authors><pubmed_authors>Fahed R</pubmed_authors><pubmed_authors>Quintero-Consuegra M</pubmed_authors><pubmed_authors>MAD MT Investigators</pubmed_authors><pubmed_authors>Li YL</pubmed_authors><pubmed_authors>Faizy TD</pubmed_authors><pubmed_authors>Shaikh H</pubmed_authors><pubmed_authors>Biswas A</pubmed_authors><pubmed_authors>Salazar-Marioni S</pubmed_authors><pubmed_authors>Marnat G</pubmed_authors><pubmed_authors>Henninger N</pubmed_authors><pubmed_authors>Guenego A</pubmed_authors><pubmed_authors>Gonzalez NR</pubmed_authors><pubmed_authors>Kuhn AL</pubmed_authors><pubmed_authors>Bellante F</pubmed_authors><pubmed_authors>Vagal A</pubmed_authors><pubmed_authors>Kalsoum E</pubmed_authors><pubmed_authors>Fuschi M</pubmed_authors><pubmed_authors>Dmytriw AA</pubmed_authors><pubmed_authors>Colasurdo M</pubmed_authors><pubmed_authors>Abdalkader M</pubmed_authors><pubmed_authors>Heit JJ</pubmed_authors><pubmed_authors>Siegler JE</pubmed_authors><pubmed_authors>Clarencon F</pubmed_authors><pubmed_authors>Renieri L</pubmed_authors><pubmed_authors>Yeo LL</pubmed_authors><pubmed_authors>Berge J</pubmed_authors><pubmed_authors>Aziz-Sultan MA</pubmed_authors><pubmed_authors>Klein P</pubmed_authors><pubmed_authors>Forestier G</pubmed_authors><pubmed_authors>Musmar B</pubmed_authors><pubmed_authors>Lakhani D</pubmed_authors><pubmed_authors>Stapleton CJ</pubmed_authors><pubmed_authors>El Naamani K</pubmed_authors><pubmed_authors>Hecker C</pubmed_authors><pubmed_authors>Wintermark M</pubmed_authors><pubmed_authors>Simonato D</pubmed_authors><pubmed_authors>Fiehler J</pubmed_authors><pubmed_authors>Elhorany M</pubmed_authors><pubmed_authors>Schiphorst AT</pubmed_authors><pubmed_authors>Griessenauer CJ</pubmed_authors><pubmed_authors>Dofuku S</pubmed_authors><pubmed_authors>Harker P</pubmed_authors><pubmed_authors>Premat K</pubmed_authors><pubmed_authors>Costalat V</pubmed_authors><pubmed_authors>Cuellar-Saenz HH</pubmed_authors><pubmed_authors>Scarcia L</pubmed_authors><pubmed_authors>Capirossi C</pubmed_authors><pubmed_authors>Varela R</pubmed_authors><pubmed_authors>Baker A</pubmed_authors><pubmed_authors>Gopinathan A</pubmed_authors><pubmed_authors>Regenhardt RW</pubmed_authors><pubmed_authors>Kadirvel R</pubmed_authors><pubmed_authors>Liebeskind DS</pubmed_authors><pubmed_authors>Hsieh CY</pubmed_authors><pubmed_authors>Weyland C</pubmed_authors><pubmed_authors>Mounayer C</pubmed_authors><pubmed_authors>Essibayi MA</pubmed_authors><pubmed_authors>Martinez-Gutierrez JC</pubmed_authors><pubmed_authors>Sibon I</pubmed_authors><pubmed_authors>Mowla A</pubmed_authors><pubmed_authors>Killer-Oberpfalzer M</pubmed_authors><pubmed_authors>Puri AS</pubmed_authors><pubmed_authors>Rabinov JD</pubmed_authors><pubmed_authors>Meyer L</pubmed_authors><pubmed_authors>Khalife J</pubmed_authors><pubmed_authors>Altschul D</pubmed_authors><pubmed_authors>Tan BY</pubmed_authors><pubmed_authors>Stracke CP</pubmed_authors><pubmed_authors>Tancredi I</pubmed_authors><pubmed_authors>Amllay A</pubmed_authors><pubmed_authors>Ota T</pubmed_authors><pubmed_authors>Jesser J</pubmed_authors><pubmed_authors>Dyzmann C</pubmed_authors><pubmed_authors>Gory B</pubmed_authors><pubmed_authors>Lubicz B</pubmed_authors><pubmed_authors>Valente I</pubmed_authors><pubmed_authors>Jabbour P</pubmed_authors><pubmed_authors>Aziz Y</pubmed_authors><pubmed_authors>Khandelwal P</pubmed_authors><pubmed_authors>Radu RA</pubmed_authors><pubmed_authors>Adeeb N</pubmed_authors><pubmed_authors>Sheth S</pubmed_authors><pubmed_authors>Patel AB</pubmed_authors><pubmed_authors>Hajjeh O</pubmed_authors><pubmed_authors>Nguyen TN</pubmed_authors><pubmed_authors>Nedelcu S</pubmed_authors><pubmed_authors>Tjoumakaris SI</pubmed_authors><pubmed_authors>Ghozy S</pubmed_authors><pubmed_authors>Kan PT</pubmed_authors><pubmed_authors>Thomas AJ</pubmed_authors><pubmed_authors>Sundararajan SH</pubmed_authors><pubmed_authors>Dusart A</pubmed_authors><pubmed_authors>Salim HA</pubmed_authors><pubmed_authors>Chervak L</pubmed_authors><pubmed_authors>Saleme S</pubmed_authors><pubmed_authors>Alexandre AM</pubmed_authors><pubmed_authors>Rouchaud A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Hypoperfusion intensity ratio is associated with follow-up infarct volume in medium vessel occlusions: A multicenter multinational study.</name><description>Medium vessel occlusion (MeVO) contributes significantly to acute ischemic stroke (AIS). The hypoperfusion intensity ratio (HIR), reflecting collateral circulation via the ratio of Tmax >10s to Tmax >6s volumes, predicts infarct progression in large-vessel occlusions but is unstudied in MeVOs. In this multicenter, multinational retrospective study, we evaluated consecutive patients with MeVO who underwent mechanical thrombectomy with or without intravenous thrombolysis. Inclusion required available follow-up imaging and pretreatment CT perfusion. Follow-up infarct volume (FIV) was measured on CT or MRI 12-36 ​h post-procedure. Univariable and multivariable linear regression models were used to identify predictors of FIV, with HIR as the primary variable of interest. Among 147 patients (med</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-05T21:33:12.605Z</modification><creation>2026-05-22T03:11:37.452Z</creation></dates><accession>S-EPMC12664488</accession><cross_references><pubmed>40829981</pubmed><doi>10.1016/j.neurot.2025.e00713</doi></cross_references></HashMap>